• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《纪念症状评估量表》土耳其语版本在癌症患者中的信效度研究

Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients.

作者信息

Yildirim Yasemin, Tokem Yasemin, Bozkurt Nilufer, Fadiloglu Cicek, Uyar Meltem, Uslu Ruchan

机构信息

Department of Internal Medicine Nursing, Ege University, Izmir, Turkey.

出版信息

Asian Pac J Cancer Prev. 2011;12(12):3389-96.

PMID:22471486
Abstract

AIM

The Memorial Symptom Assessment Scale (MSAS) is a multidimensional tool developed to evaluate measure the prevalence, characteristics and distress of common symptoms related to cancer. A validated Turkish version has now become available. The aim of this study was to evaluate its reliability and validity.

METHODS

One hundred-twenty patients were included into this study. The MSAS, The Rotterdam Symptom Checklist (RSCL), and Karnofsky Performance Status Scale (KPSS) were used for data collection. Content and criterion validities were examined. Reliability analyses of the MSAS were performed using internal consistency reliability and test-retest reliability.

RESULTS

The most frequently reported symptom (90%) was problems with sexual interest or activity. Item-total correlations ranged between 0.03 and 0.64. There was a high correlation between total MSAS and the RSCL (r=0.875, p<0.01). The internal consistency reliabilities of subscales of the MSAS and total MSAS were moderately high, with Cronbach alpha coefficients ranging from 0.71 to 0.84. The MSAS's test - re-test reliability was 0.78.

CONCLUSION

The MSAS for cancer patients was determined to be a valid and reliable instrument for the use in the Turkish population. It is recommended that the MSAS-Turkish version can be used as a tool for comprehensive symptom assessment in planning nursing care for cancer patients.

摘要

目的

纪念症状评估量表(MSAS)是一种多维工具,旨在评估癌症相关常见症状的患病率、特征和痛苦程度。现已推出经过验证的土耳其语版本。本研究的目的是评估其信度和效度。

方法

本研究纳入了120名患者。使用MSAS、鹿特丹症状清单(RSCL)和卡诺夫斯基功能状态量表(KPSS)进行数据收集。检验了内容效度和效标效度。使用内部一致性信度和重测信度对MSAS进行信度分析。

结果

最常报告的症状(90%)是性兴趣或活动方面的问题。项目与总分的相关性在0.03至0.64之间。MSAS总分与RSCL之间存在高度相关性(r = 0.875,p < 0.01)。MSAS各子量表和MSAS总分的内部一致性信度中等偏高,克朗巴赫α系数在0.71至0.84之间。MSAS的重测信度为0.78。

结论

癌症患者的MSAS被确定为在土耳其人群中使用的有效且可靠的工具。建议将MSAS土耳其语版本用作癌症患者护理计划中综合症状评估的工具。

相似文献

1
Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients.《纪念症状评估量表》土耳其语版本在癌症患者中的信效度研究
Asian Pac J Cancer Prev. 2011;12(12):3389-96.
2
Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale.评估中国癌症患者的症状体验:中文版纪念症状评估量表的验证
J Pain Symptom Manage. 2009 Jan;37(1):44-57. doi: 10.1016/j.jpainsymman.2007.12.019. Epub 2008 Jun 6.
3
Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.《纪念症状评估量表(MSAS)瑞典语版的有效性和可靠性:用于评估症状发生率、特征和痛苦的工具》。
J Pain Symptom Manage. 2013 Jul;46(1):131-41. doi: 10.1016/j.jpainsymman.2012.07.023. Epub 2012 Nov 27.
4
Reliability and Validity of the Korean Memorial Symptom Assessment Scale-Short Form in Gynecological Cancer Patients.韩国纪念症状评估量表-简表在妇科癌症患者中的信度和效度。
J Pain Symptom Manage. 2018 Jan;55(1):101-107. doi: 10.1016/j.jpainsymman.2017.08.023. Epub 2017 Sep 1.
5
New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS).症状评估的新见解:纪念症状评估量表简表(MSAS-SF)和精简版MSAS(CMSAS)的中文版
J Pain Symptom Manage. 2008 Dec;36(6):584-95. doi: 10.1016/j.jpainsymman.2007.12.008. Epub 2008 Apr 22.
6
The memorial symptom assessment scale short form (MSAS-SF).简明纪念症状评估量表(MSAS-SF)。
Cancer. 2000 Sep 1;89(5):1162-71. doi: 10.1002/1097-0142(20000901)89:5<1162::aid-cncr26>3.0.co;2-y.
7
Measuring the Symptom Experience of Patients With Cancer in Indonesia: Cross-Cultural Adaptation and Validation of the Memorial Symptom Assessment Scale-Indonesian Version.测量印度尼西亚癌症患者的症状体验:纪念症状评估量表印度尼西亚版的跨文化调适和验证。
J Pain Symptom Manage. 2018 Dec;56(6):920-927. doi: 10.1016/j.jpainsymman.2018.08.016. Epub 2018 Aug 31.
8
Validation of the Simplified Chinese Version of the Memorial Symptom Assessment Scale-Short Form Among Cancer Patients.癌症患者简明症状评估量表简体中文版的验证。
J Pain Symptom Manage. 2018 Jul;56(1):113-121. doi: 10.1016/j.jpainsymman.2018.03.024. Epub 2018 Apr 5.
9
Reliability and Validity of the Spanish Version of the Memorial Symptom Assessment Scale in Oncology Patients.《纪念症状评估量表西班牙语版在肿瘤患者中的信效度》
J Pain Symptom Manage. 2016 Dec;52(6):884-891. doi: 10.1016/j.jpainsymman.2016.05.021. Epub 2016 Sep 30.
10
The psychometric properties of the Hebrew version of the Memorial Symptom Assessment scale (MSAS-Heb) in patients with breast cancer.纪念症状评估量表希伯来语版(MSAS-Heb)在乳腺癌患者中的心理测量学特性。
J Pain Symptom Manage. 2015 Apr;49(4):790-5. doi: 10.1016/j.jpainsymman.2014.08.016. Epub 2014 Sep 28.

引用本文的文献

1
The effectiveness of reminiscence therapy on the symptom management, the life satisfaction, and the self-transcendence in palliative care patients: a randomized controlled trial.回忆疗法对姑息治疗患者症状管理、生活满意度和自我超越的有效性:一项随机对照试验。
Support Care Cancer. 2024 Jun 14;32(7):431. doi: 10.1007/s00520-024-08626-9.
2
Symptom Prevalence in Spanish and Colombian Oncology Patients Measured with the MSAS.用MSAS测量西班牙和哥伦比亚肿瘤患者的症状患病率。
Cancers (Basel). 2022 Mar 23;14(7):1624. doi: 10.3390/cancers14071624.
3
Determining the symptoms and coping methods of patients at home after hematopoietic stem cell transplantation.
确定造血干细胞移植后患者在家中的症状及应对方法。
Support Care Cancer. 2022 Jul;30(7):5881-5890. doi: 10.1007/s00520-022-07017-2. Epub 2022 Apr 4.
4
Progress in palliative care for cancer in Turkey: a review of the literature.土耳其癌症姑息治疗的进展:文献综述
Ecancermedicalscience. 2021 Nov 25;15:1321. doi: 10.3332/ecancer.2021.1321. eCollection 2021.
5
Symptom Clustering and Its Effect on Functional Status in Lymphoma Patients.淋巴瘤患者的症状聚类及其对功能状态的影响。
Florence Nightingale J Nurs. 2020 Jul 3;28(2):143-154. doi: 10.5152/FNJN.2020.19107. eCollection 2020 Jun.
6
The usefulness and prognostic value of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in assessment of lung cancer patients.纪念症状评估-短表和简化纪念症状评估量表在评估肺癌患者中的作用和预后价值。
Support Care Cancer. 2020 Apr;28(4):2005-2014. doi: 10.1007/s00520-019-05003-9. Epub 2019 Aug 6.
7
Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy.接受化疗的肿瘤患者中,胃肠道症状并存与味觉改变相关。
J Pain Symptom Manage. 2019 Nov;58(5):756-765. doi: 10.1016/j.jpainsymman.2019.07.016. Epub 2019 Jul 23.
8
Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs.接受紫杉烷类药物治疗的乳腺癌患者的症状体验与生活质量
Eur J Breast Health. 2018 Jul 1;14(3):148-155. doi: 10.5152/ejbh.2018.3785. eCollection 2018 Jul.
9
Symptoms Experienced and Information Needs of Women Receiving Chemotherapy.接受化疗的女性所经历的症状及信息需求
Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):178-183. doi: 10.4103/apjon.apjon_69_17.
10
The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy.结构化教育对接受口服抗癌药物治疗患者的用药依从性和自我效能的影响。
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):290-298. doi: 10.4103/apjon.apjon_35_17.